{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:55:03Z","timestamp":1789430103083,"version":"build-2803163510"},"reference-count":74,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dry eye is a common inflammatory condition of the ocular surface. While oral omega-3 supplementation for its treatment has been extensively studied, recent large-scale studies have cast doubt on their efficacy. However, efficacy of topical omega-3 has yet to be reviewed. We performed a systematic search of PubMed, Embase, and Cochrane databases for all studies evaluating topical omega-3 in dry eye. Five human and five animal studies were included. Of the five human studies, two were on dry eye disease (DED), one was on contact lens discomfort, and two were on patients undergoing corneal collagen crosslinking. In humans, there is promising evidence for improved ocular surface staining and tear break-up time compared to controls, equivocal evidence for improvements to ocular surface symptoms and meibomian gland dysfunction, and no effect on increasing tear production. Data from animal models largely agree with these findings, and further reveal decreased inflammatory cytokines and monocyte infiltration. Our review suggests that topical omega-3 is a promising treatment for dry eye, but also points to the paucity of evidence in this field. Further trials in humans are required to characterize effects of topical omega-3 and optimize its dosage.<\/jats:p>","DOI":"10.3390\/ijms232113156","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:26:50Z","timestamp":1667114810000},"page":"13156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Topical Omega-3 Fatty Acids Eyedrops in the Treatment of Dry Eye and Ocular Surface Disease: A Systematic Review"],"prefix":"10.3390","volume":"23","author":[{"given":"Benjamin","family":"Paik","sequence":"first","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3986-6552","authenticated-orcid":false,"given":"Louis","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Cornea and External Eye Disease, Singapore National Eye Center, Singapore 168751, Singapore"},{"name":"Ocular Surface Research Group, Singapore Eye Research Institute, Singapore 169856, Singapore"},{"name":"Ophthalmlogy and Visual Sciences Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2018.06.002","article-title":"Dry Eye Assessment and Management (DREAM\u00a9) Study: Study design and baseline characteristics","volume":"71","author":"Asbell","year":"2018","journal-title":"Contemp. Clin. Trials"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: A decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: An immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3889\/oamjms.2018.215","article-title":"The Correlation between Daily Lens Wear Duration and Dry Eye Syndrome","volume":"6","author":"Lubis","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ophtha.2008.06.022","article-title":"Prevalence of dry eye disease among Japanese visual display terminal users","volume":"115","author":"Uchino","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.sjopt.2018.10.009","article-title":"Incidence and pattern of dry eye after cataract surgery","volume":"33","author":"Ishrat","year":"2019","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108115","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3906\/sag-2002-143","article-title":"The negative effects of dry eye disease on quality of life and visual function","volume":"50","author":"Guo","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11296","DOI":"10.1038\/s41598-018-29568-3","article-title":"Tear eicosanoids in healthy people and ocular surface disease","volume":"8","author":"Ambaw","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.preteyeres.2004.04.003","article-title":"Changes in the tear film and ocular surface from dry eye syndrome","volume":"23","author":"Johnson","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: Importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: A focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_14","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.18773\/austprescr.2018.048","article-title":"Dry eye disease: When to treat and when to refer","volume":"41","author":"Findlay","year":"2018","journal-title":"Aust. Prescr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjophthalmol-2019-315747","article-title":"Modern approach to the treatment of dry eye, a complex multifactorial disease: A P.I.C.A.S.S.O. board review","volume":"105","author":"Aragona","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_18","first-page":"e3506","article-title":"Cyclosporine-induced Erythromelalgia","volume":"10","author":"Bibb","year":"2018","journal-title":"Cureus"},{"key":"ref_19","first-page":"1487","article-title":"New concepts in nutraceuticals as alternative for pharmaceuticals","volume":"5","author":"Nasri","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"ref_20","first-page":"106","article-title":"Cod and the Consumptive: A Brief History of Cod-Liver Oil in the Treatment of Pulmonary Tuberculosis","volume":"46","author":"Grad","year":"2004","journal-title":"Pharm. Hist."},{"key":"ref_21","first-page":"8","article-title":"Mother was right about cod liver oil","volume":"10","author":"Griffing","year":"2008","journal-title":"Medscape J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e00095-21","DOI":"10.1128\/IAI.00095-21","article-title":"Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections","volume":"89","year":"2021","journal-title":"Infect. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"201929","DOI":"10.1155\/2010\/201929","article-title":"Eicosanoids in the Innate Immune Response: TLR and Non-TLR Routes","volume":"2010","author":"Alvarez","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajcn\/83.2.331","article-title":"Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men","volume":"83","author":"Rees","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","article-title":"Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids","volume":"68","author":"Wall","year":"2010","journal-title":"Nutr. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution","volume":"27","author":"Serhan","year":"2015","journal-title":"Semin. Immunol."},{"key":"ref_27","first-page":"Cd011016","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease","volume":"12","author":"Downie","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preteyeres.2017.05.003","article-title":"The role of systemic and topical fatty acids for dry eye treatment","volume":"61","author":"Barabino","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease","volume":"378","author":"Asbell","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtos.2019.08.002","article-title":"The Dry Eye Assessment and Management (DREAM) extension study\u2014A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease","volume":"18","author":"Hussain","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: An overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MCO.0b013e328342bb1a","article-title":"Docosahexaenoic acid, protectins and dry eye","volume":"14","author":"Cortina","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1167\/iovs.16-19131","article-title":"\u03c9-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye","volume":"57","author":"Walter","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1167\/iovs.09-3641","article-title":"Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA","volume":"51","author":"Cortina","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/ICO.0b013e31823f789e","article-title":"Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye","volume":"31","author":"Schwartz","year":"2012","journal-title":"Cornea"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2010.0019","article-title":"Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model","volume":"26","author":"Li","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_39","unstructured":"(2022, September 16). National Heart, Lung, and Blood Institute. Study Quality Assessment Tools, Available online: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/jop.2021.0102","article-title":"A Water-Free Omega-3 Fatty Acid Eye Drop Formulation for the Treatment of Evaporative Dry Eye Disease: A Prospective, Multicenter Noninterventional Study","volume":"38","author":"Jacobi","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_41","first-page":"959","article-title":"Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking: Short term results","volume":"30","author":"Tunc","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10792-019-01170-0","article-title":"Efficacy of topical microemulsion of fatty acids of the \u03c9-3 series on the sub-epithelial corneal nerves regeneration after epithelium-off corneal collagen cross-linking for keratoconus","volume":"40","author":"Cagini","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jtos.2019.11.004","article-title":"An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial","volume":"18","author":"Downie","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1167\/iovs.18-24758","article-title":"Modulating Contact Lens Discomfort With Anti-Inflammatory Approaches: A Randomized Controlled Trial","volume":"59","author":"Downie","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_45","first-page":"3688","article-title":"Safety and Efficacy of Topical 1% docosahexaenoic acid (DHA) and 1% alpha-linoleic acid (ALA) in a Canine Model","volume":"55","author":"Damani","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.colsurfb.2018.09.063","article-title":"Potentiality of microemulsion systems in treatment of ophthalmic disorders: Keratoconus and dry eye syndrome\u2014In vivo study","volume":"173","author":"Lidich","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1869-5760-3-4","article-title":"Use of linseed oil to treat experimentally induced keratoconjunctivitis sicca in rabbits","volume":"3","author":"Neves","year":"2013","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/02713683.2014.884595","article-title":"Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye","volume":"39","author":"Li","year":"2014","journal-title":"Curr. Eye Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamaophthalmol.2015.4518","article-title":"Corneal Nerve Regeneration After Collagen Cross-Linking Treatment of Keratoconus: A 5-Year Longitudinal Study","volume":"134","author":"Parissi","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sun, M., Moreno, I.Y., Dang, M., and Coulson-Thomas, V.J. (2020). Meibomian Gland Dysfunction: What Have Animal Models Taught Us?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228822"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15406\/aovs.2021.11.00403","article-title":"Evaluation of tear film instability pre and post corneal collagen cross-linking procedure in keratoconus patients","volume":"11","author":"Ahsan","year":"2021","journal-title":"Adv. Ophthalmol. Vis. Syst."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","article-title":"Corneal nerves in health and disease","volume":"59","author":"Shaheen","year":"2014","journal-title":"Surv. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"610342","DOI":"10.3389\/fncel.2020.610342","article-title":"Morphological and Functional Changes of Corneal Nerves and Their Contribution to Peripheral and Central Sensory Abnormalities","volume":"14","author":"Baudouin","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1167\/iovs.16-19757","article-title":"Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease","volume":"57","author":"Jackson","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.exer.2015.08.024","article-title":"In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells","volume":"140","author":"Hampel","year":"2015","journal-title":"Exp. Eye Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010033344480","article-title":"Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: Therapeutical implications","volume":"2","author":"Amerio","year":"2003","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Crawford, A., Angelosanto, J.M., Nadwodny, K.L., Blackburn, S.D., and Wherry, E.J. (2011). A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002098"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Guerrero-Moreno, A., Liang, H., Moreau, N., Luzu, J., Rabut, G., Melik Parsadaniantz, S., Labb\u00e9, A., Baudouin, C., and R\u00e9aux-Le Goazigo, A. (2021). Corneal Nerve Abnormalities in Painful Dry Eye Disease Patients. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101424"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/aos.13844","article-title":"Role of corneal nerves in ocular surface homeostasis and disease","volume":"97","author":"Labetoulle","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","article-title":"Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection","volume":"81","author":"Bazan","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Calon, F., Julien, C., Winkler, J.W., Petasis, N.A., Lukiw, W.J., and Bazan, N.G. (2011). Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPAR\u03b3-Mediated Mechanisms in Alzheimer\u2019s Disease Models. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0015816"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/acs.biochem.0c00931","article-title":"In Vitro Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2","volume":"60","author":"Tsai","year":"2021","journal-title":"Biochemistry"},{"key":"ref_66","first-page":"6304","article-title":"Pigment Epithelium Derived Factor (PEDF) Increases After Corneal Epithelial Injury and Stimulates the Expression of 15-Lox1","volume":"50","author":"Li","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"100033","DOI":"10.1194\/jlr.TR120000954","article-title":"Docosanoid signaling modulates corneal nerve regeneration: Effect on tear secretion, wound healing, and neuropathic pain","volume":"62","author":"Pham","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12492","DOI":"10.1096\/fj.202000483R","article-title":"Eosinophils promote corneal wound healing via the 12\/15-lipoxygenase pathway","volume":"34","author":"Ogawa","year":"2020","journal-title":"FASEB J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","article-title":"Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies","volume":"73","author":"Singh","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Agarwal, P., Craig, J.P., and Rupenthal, I.D. (2021). Formulation Considerations for the Management of Dry Eye Disease. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020207"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"120924","DOI":"10.1016\/j.ijpharm.2021.120924","article-title":"Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies","volume":"607","author":"Mofidfar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/eurheartj\/ehu467","article-title":"Wilder\u2019s principle: Pre-treatment value determines post-treatment response","volume":"36","author":"Messerli","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3892\/etm.2021.10830","article-title":"Animal models of dry eye disease: Useful, varied and evolving (Review)","volume":"22","author":"Huang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/APO.0000000000000417","article-title":"Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework","volume":"10","author":"Tong","year":"2021","journal-title":"Asia-Pac. J. Ophthalmol. (Phila)"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:05:34Z","timestamp":1760144734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":74,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232113156"],"URL":"https:\/\/doi.org\/10.3390\/ijms232113156","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]}}}